bladder neck
apex
median lobe
para-collecular
B. apex
prostate sizes of up to 70 ml can be treated
not recommended in patients with metallic artificial hip
retreatment rates are lower than for TURP
can be performed in an office-based setting
tamsulosin 0.8 mg
reassurance
repeat total and free PSA
diagnostic cystoscopy
operation time
duration of in-hospital stay
amount of blood transfused
time to catheter removal
bladder stones
prostate cancer
renal insufficiency
bladder diverticula
bladder trabeculation
significant PVR
low peak flow rate
high IPSS
smaller incisions with a shorter hospital stay
lower risk for blood transfusion
none of the above
. What is the first-line management of uncomplicated LUTS due to large prostate?
calcium channel blockers
antihistamines
antidepressants
cold medications containing pseudoephedrine
tuberculous prostatitis
prostatic cancer
inspissated prostatic abscess
any of the above
TUIP
TURP
HoLEP
HoLRP
anterior
median
left lateral
all of the above
an additional 15 g in prostate weight
each centimeter over the normal 1.5-cm prostate urethral length equates
an additional 5 g in prostate weight
. When comparing suprapubic to retropubic prostatectomy for removing prostatic adenoma, the former allows:
is specific for prostate symptom
is a seven-question, self-administered questionnaire that yields a total score that ranges from 0 to 35
a sum of 20 on IPSS scale is severe
it covers both voiding and storage symptomatology
provides tissue preservation for pathological examination
treats any size of prostatic adenoma
follows anatomic planes to remove the prostate in lobes
urinary incontinence is a significant drawback after HoLEP
peak flow rate of ≤ 12 mL/sec
prostate volume > 40 ml
PSA > 1.5 ng/dL
b & c
it may develop detrusor instability with irritative LUTS
it may develop poor compliance with frequency and urgency symptoms
it may develop poor detrusor contractility with obstructive LUTS
all of the above
worsening of LUTS and BPH over time
patients die of other reasons before serious complications occur
physically, the space of prostatic fossa limits the gland enlargement
ultimately, the gland will degenerate and undergo apoptosis
bladder stones
BPH
prostatitis syndrome
. What is (are) the indication(s) of antimuscarinic agents and PDEIs
small prostate
mainly median lobe hypertrophy
history of urinary retention
mainly irritative symptoms
combination of α-adrenergic blocker and 5α-reductase inhibitor
watchful waiting
TURP
. What is the commonest cause of LUTS in men beyond middle age?
the glandular component of the prostate
the IPSS questionnaire points
the PVR
the transitional zone volume
IPSS
post void residual
prostate volume
Q-max at uroflowmetry
PSA > 1.5 ng/dL
prostate volume > 40 ml
IPSS > 19
a & b
cetrorelix
flutamide
dutasteride
zanoterone
urolithiasis
receiving chemotherapy
upper tract surgery
painless hematuria
there is an increase in the number of epithelial and stromal cells
there is an increase in the size of epithelial and stromal cells
in BPH, epithelial to stromal cells ratio is 1:2
all of the above
tamsulosin
alfuzosin
doxazosin
silodosin
go for urine cytology testing
go for PSA testing
go for TRUS
use anticholinergic medication
the presence of prostate cancer
previous prostatectomy
all of the above
. Robot-assisted laparoscopic prostatectomy for prostatic adenoma has the following advantage over TURP:
as a man ages, the responsiveness of prostate cells to androgenic stimuli decreases
adrenal androgens have no role in BPH development
type-1 steroid 5 α-reductase is functionally active in the hair follicle
all of the above
obstruction results in bladder smooth muscle hypertrophy and myofibroblasts deposition
BPH occurs chiefly in the transitional zone and periurethral tissues
BPH microscopical changes begin in early thirties
histologic findings of chronic prostatitis are common in BPH